Biodistribution of [11C]PIB in Patients With Risk Factors for Alzheimer's Disease

Part of paid clinical trials in Winston-Salem, North Carolina.

Sponsor
Wake Forest University Health Sciences
Study ID
NCT03089827
Status
Enrolling By Invitation

Conditions

Eligibility Criteria

Sex
ALL
Age
55 Years - N/A
Healthy Volunteers
Accepted

Study Details

Participants enrolled at the Alzheimer's Disease Research Center (ADRC) at Wake Forest School of Medicine will be invited to take part in this study. The purpose of this study is to identify and measure the amount of a protein called amyloid in the brain.It is thought that the build up of amyloid may be related to the development of Alzheimer's disease.

Key Dates

Start date
May 21, 2014
Status verified
Dec 2025
Primary completion
Apr 30, 2030
Completion
Apr 30, 2031

Study Design

Enrollment
800 participants (estimated)

Primary Outcome Measure

Amyloid deposition [ Time Frame: 2 years ]

Locations (1)

FacilityCityStateZIPSite coordinators
Wake Forest Baptist Medical CenterWinston-SalemNorth Carolina27157-

Find similar trials in Winston-Salem, NC

By condition
Alzheimer's disease
By specialty
NeurologyDementia careBrain disordersGeriatrics
By research site
Wake Forest Baptist Medical Center· Winston-Salem, NC

Related Studies